Table 1 Demographics and diabetes history of study population

Female sex, n (%)

188 (58.8%)

162 (55.5%)

Age (years), median [Q1, Q3]

33.0 [26.0, 44.0]

62.0 [55.0, 68.5]

Full-time employment, n (%)

136 (45.5%)

58 (21.2%)

Duration of diabetes (years), median [Q1, Q3]

15.0 [9.0, 22.0]

15.0 [10.0, 22.0]

Last measured HbA1c value (%), median [Q1, Q3]

7.7 [7.0, 8.5]

7.9 [7.3, 9.1]

Checks blood sugar levels, n (%)

314 (98.4%)

259 (88.7%)

Has ever experienced hypoglycemia, n (%)

313 (97.5%)

247 (84.3%)

(if yes) Patients identifying hypoglycemia based on, n (%)

 Symptoms only

83 (27.4%)

96 (41.4%)

 Blood glucose measurement only

23 (7.6%)

38 (16.4%)

 Either symptoms or a blood glucose measurement

56 (18.5%)

28 (12.1%)

 Both symptoms and blood glucose measurement

129 (42.6%)

65 (28.0%)

 Other

12 (4.0%)

5 (2.2%)

 Missing

18

61

Duration of insulin use (years), median [Q1, Q3]

14.0 [8.0, 22.0]

6.0 [3.0, 10.0]

Diabetes treatment, n (%)^a

 Only short-acting insulin

26 (8.2%)

15 (5.1%)

 Only long-acting insulin

14 (4.4%)

123 (42.0%)

 Both short- and long-acting insulin

250 (77.9%)

137 (46.8%)

 Mixed insulin

12 (3.8%)

11 (3.8%)

 Insulin pump

17 (5.3%)

1 (0.3%)

 Oral anti-diabetes treatment

29 (9.1%)

177 (60.4%)

 Injectable anti-diabetes treatments other than insulin

44 (13.8%)

4 (1.4%)

Patients who completed second questionnaire

276 (86.0%)

254 (86.7%)